Site map
About EPI
About CREON
Dosing & Administration
Resources & Patient Support
Access & Coverage
About EPI
About CREON
Dosing & Administration
Resources & Patient Support
Access & Coverage
CREON® (pancrelipase) Delayed-Release Capsules is a pancrelipase which is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions.
Please see Full Prescribing Information.
US-CREO-220154
Reference: 1. CREON [package insert]. North Chicago, IL: AbbVie Inc.